EB150: Statement of Knowledge Ecology International (KEI) on the Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases

Posted on by Thiru

On Wednesday, 26 January 2022, Knowledge Ecology International (KEI) delivered the following statement on the Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases and WHO’s roadmap for the global… Continue Reading →

EB150 – Statement of Knowledge Ecology International (KEI) on Public health emergencies: preparedness and response

Posted on by Thiru

On Wednesday, 26 January 2022, Knowledge Ecology International (KEI) delivered the following statement on a possible pandemic treaty at the 150th session of the World Health Organization’s Executive Board. The WHO negotiations on a pandemic treaty are not a quick… Continue Reading →

Xtandi Bayh-Dole Rights Case: Memorandum in Support of Prostate Cancer Patient Petition Asking HHS to Use the US Government’s Rights in Patents to Enable Generic Competition

Posted on by Claire Cassedy

(For more information, please see the Xtandi: 2021-2022 request page) A January 25, 2022 Knowledge Ecology International “Memorandum in support of the petition to HHS to exercise the march-in or paid up royalty right in patents on the prostate drug… Continue Reading →

KEI Comment to the NIH Regarding Exclusive License of Anti-Viral Prevention and Treatment

Posted on by KEI Staff

On Wednesday January 12, 2022, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding a prospective exclusive, sublicensable license to the University of Louisville Research Foundation (ULRF), for “Griffithsin Compositions for Treatment and Prevention of… Continue Reading →

December 15th 10AM – Briefing on Xtandi March-in Request

Posted on by James Love

Update: Video recording of the press briefing available here: https://www.youtube.com/watch?v=KwqUl7NLMXo) December 15th 10AM – Briefing on Xtandi March-in Request Supporters of the march-in petition to lower the cost of the prostate cancer drug Xtandi will host a virtual press conference… Continue Reading →

Eric Sawyer December 13, 2021 Petition to HHS on Xtandi March-in Case

Posted on by Claire Cassedy

On December 13, 2021, Eric Sawyer filed this petition with the Department of Health and Human Services, asking to join an outstanding march-in petition on the patents for the prostate cancer drug enzalutamide, sold under the brand name Xtandi by… Continue Reading →

HHS Asked to Take Up March-in Request of Prostate Cancer Drug Xtandi

Posted on by Claire Cassedy

(Update: On December 15, 2021 KEI hosted a press briefing regarding the Xtandi march-in request. Video and details available here: https://www.youtube.com/watch?v=KwqUl7NLMXo) On November 18, 2021, Robert Sachs and Clare Love submitted a petition to the Secretary of Health and Human… Continue Reading →

KEI letter to Brian Nelson, Office of Terrorism and Financial Intelligence, regarding exceptions to sanctions for medical products

Posted on by KEI Staff

KEI is sending this letter to the Administration today, regarding measures we would like to see undertaken to make the humanitarian exceptions to sanctions work better.  This is a neglected area of policy failure, although there is evidence that the Biden administration… Continue Reading →

WIPO SCP 33: Opening statement of Asia and Pacific Group stresses that WIPO “ought to give primacy to the issues of Public Health and Transfer of Technology”

Posted on by Thiru

On Monday, 6 December 2021, India delivered an opening statement on behalf of the Asia and Pacific Group (AGP). The Islamic Republic of Iran, Bangladesh, Singapore, Indonesia, United Arab Emirates, and the Republic of Korea are just a few of… Continue Reading →